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O R I G I N A L AR T I C LE

Temperament, character and serotonin activity in the
human brain: a positron emission tomography study
based on a general population cohort
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Background. The psychobiological model of personality by Cloninger and colleagues originally hypothesized
that interindividual variability in the temperament dimension ‘ harm avoidance ’ (HA) is explained by diﬀerences in
the activity of the brain serotonin system. We assessed brain serotonin transporter (5-HTT) density in vivo with
positron emission tomography (PET) in healthy individuals with high or low HA scores using an ‘ oversampling ’
study design.
Method. Subjects consistently in either upper or lower quartiles for the HA trait were selected from a populationbased cohort in Finland (n=2075) with pre-existing Temperament and Character Inventory (TCI) scores. A total
of 22 subjects free of psychiatric and somatic disorders were included in the matched high- and low-HA groups.
The main outcome measure was regional 5-HTT binding potential (BPND) in high- and low-HA groups estimated
with PET and [11C]N,N-dimethyl-2-(2-amino-4-methylphenylthio)benzylamine ([11C]MADAM). In secondary analyses, 5-HTT BPND was correlated with other TCI dimensions.
Results. 5-HTT BPND did not diﬀer between high- and low-HA groups in the midbrain or any other brain region.
This result remained the same even after adjusting for other relevant TCI dimensions. Higher 5-HTT BPND in the
raphe nucleus predicted higher scores in ‘ self-directedness ’.
Conclusions. This study does not support an association between the temperament dimension HA and serotonin
transporter density in healthy subjects. However, we found a link between high serotonin transporter density and
high ‘ self-directedness ’ (ability to adapt and control one’s behaviour to ﬁt situations in accord with chosen goals and
values). We suggest that biological factors are more important in explaining variability in character than previously
thought.
Received 3 January 2012 ; Revised 5 June 2012 ; Accepted 19 June 2012 ; First published online 31 July 2012
Key words : Harm avoidance, healthy volunteers, neuroimaging, personality, positron emission tomography,
serotonin, serotonin transporter.

Introduction
Since the launching of the ﬁrst academic personality
theory by Gordon Allport in 1937 (Allport, 1937),
personality has been seen as a dynamic organization
that determines one’s unique adjustment to the

* Address for correspondence : J. Hietala, M.D., Department of
Psychiatry, University of Turku, Kunnallissairaalantie 20, Building 9,
20700-Turku, Finland.
(Email : jahi@utu.ﬁ)

environment. While the themes of this dynamic
organization are not shared by all personality theories,
they all suggest that personality is subject to biological
and psychological inﬂuences. Thus, the personalitydetermined adaptations are unique to each individual
because of diﬀerences in heredity and environment.
The most recent personality theory that shares
Allport’s concept of personality as an adaptation
system is Cloninger’s psychobiological personality
concept (Cloninger et al. 1993). According to this
theory, personality consists of seven dimensions that
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are postulated to cover the structure and development
of human personality. The model diﬀerentiates between temperament and character traits. Temperament traits are thought to reﬂect individual diﬀerences
in automatic responses to emotional stimuli. Character
traits reﬂect diﬀerences in personal aims and values
and are more inﬂuenced by environmental factors
such as social learning and mature in a stepwise
manner during development (Cloninger et al. 1993).
Cloninger proposed a division of temperament into
four diﬀerent dimensions : ‘ harm avoidance ’ (HA),
‘ novelty seeking ’, ‘ reward dependence ’ and ‘ persistence ’. HA is a bias to respond intensely to aversive
stimuli and to inhibit behaviour, ‘ novelty seeking ’ is a
bias in initiation of behaviours, like exploratory activity in response to novelty, ‘ reward dependence ’ is a
tendency to respond intensely to social approval and
‘ persistence ’ means perseverance despite frustration
and fatigue (Cloninger, 1987). Temperament is the
emotional core of personality and these traits are
thought to be genetically homogeneous, moderately
and independently heritable and normally distributed
in the general population. The ﬁrst three temperament
traits, HA, ‘ novelty seeking ’ and ‘ reward dependence ’ were also suggested to have their corresponding neurobiological substrates : serotonin, dopamine
and noradrenalin, respectively (Cloninger, 1986).
HA has been shown to be a trait that is especially
predictive of risk for aﬀective psychopathology
(Farmer & Seeley, 2009). It is thought to represent the
behavioural inhibition system of the brain (Cloninger,
1986) and by deﬁnition high harm-avoidant individuals tend to be cautious, fearful, insecure and
pessimistic. From the evolutionary point of view, high
HA is advantageous in the face of danger, because it
leads to greater care and caution. On the other hand,
when danger is unlikely, excessive pessimism and
worry are thought to predispose to aﬀective disorders
(Cloninger et al. 1994, 2006) and this has been demonstrated in a large body of studies (Farmer et al. 2003 ;
Cloninger et al. 2006 ; de Winter et al. 2007 ; Wachleski
et al. 2008 ; Minaya & Fresán, 2009). The robust associations between HA and anxiety disorders, aﬀective disorders as well as other psychiatric disorders
such as schizophrenia are summarized in a recent
meta-analysis (Miettunen & Raevuori, 2012).
However, not all individuals that have high HA
scores manifest psychiatric disorders. This observation
led Cloninger to extend his temperament model with
three character dimensions that reﬂect the maturity
and integration of personality, and are accordingly
supposed to better reﬂect an individual’s adaptation
and social adjustment (Cloninger et al. 1993). These
three character dimensions are ‘ self-directedness ’,
‘ cooperativeness ’ and ‘ self-transcendence ’ and they

modify the role of temperament in an adult personality. ‘ Self-directedness ’ is deﬁned as the extent to
which a person identiﬁes himself as an autonomous
individual and as the ability to adapt behaviour according to chosen goals and values. ‘ Self-directedness ’
is a trait that gives rise to the feelings of personal
integrity and self-esteem. ‘ Cooperativeness ’ refers to a
person’s ability to accept and identify with other
people. ‘ Self-transcendence ’ is a character trait that
refers to experiences of spirituality and feelings of
unity with the universe (Cloninger et al. 1993).
Especially low ‘ self-directedness ’ seems to be involved in diﬀerent forms of psychopathology such as
personality disorders (Svrakic et al. 1993 ; Gutierrez
et al. 2002), depression (Smith et al. 2005 ; Cloninger
et al. 2006 ; Minaya & Fresán, 2009) and anxiety-related
disorders (Wachleski et al. 2008). Considering the associations between personality traits and psychopathology, a greater understanding of their biology might
also increase the understanding of the aetiology of
emotional disorders.
The relationship between high HA and high activity
of the serotonin system was ﬁrst proposed in 1986
based on the ﬁndings in basic biochemical studies and
studies on animals. Evidence on humans that led to
the hypothesis was the ﬁndings that aggression and
violent suicidal behaviour are both related to low
serotonergic activity and these again are examples of
low harm-avoidant behaviour. Also some evidence
supported the idea that the serotonin system was related to the trait called ‘ validity ’ in Henrik Sjobring’s
model for personality, which is the antecedent of HA
(Banki & Arato, 1983 ; Cloninger et al. 1994).
Ever since this association was hypothesized it has
been the subject of numerous studies, including those
using indirect methods to deﬁne serotonergic activity
such as platelet imipramine-binding tests (Pfohl et al.
1990), platelet 5-hydroxytryptamine (5-HT)2 receptor
sensitivity tests (Peirson et al. 1999), monoamine challenging tests (Gerra et al. 2000), urinary monoamine
excretion tests (Curtin et al. 1997), cerebrospinal ﬂuid
5-hydroxyindoleacetic acid (5-HIAA) assays (Limson
et al. 1991) and clinical trials with antidepressants
(Allgulander et al. 1998 ; Boz et al. 2007). In addition to
HA, ‘ self-directedness ’ has often been correlated with
serotonergic markers (Allgulander et al. 1998 ; Peirson
et al. 1999 ; Boz et al. 2007). Results from these studies
should be seen as circumstantial evidence for the
hypothesis and inconsistencies remain, as they do in
genetic studies on HA and the serotonin system (Lesch
et al. 1996 ; Schinka et al. 2004 ; Sen et al. 2004 ; Munafò
et al. 2009).
In vivo imaging techniques, such as positron emission tomography (PET), are now able to directly
measure the serotonergic system in the living human
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brain. A total of six published studies have used
PET or single photon emission computed tomography
to examine the correlation of serotonergic neurotransmission with HA (Rabiner et al. 2002 ; Moresco
et al. 2002 ; Borg et al. 2003 ; Van Heeringen et al.
2003 ; Reimold et al. 2008 ; Karlsson et al. 2009). Van
Heeringen et al. (2003) found a negative correlation
between HA and 5-HT2A receptor marker [123I]5-IR91150 binding in nine suicidal subjects. Another
study (Moresco et al. 2002) also found a negative
correlation between 5-HT2A receptor tracer 3-(2k[18F]ﬂuoroethyl)spiperone ([18F]FESP) and HA in
healthy subjects, giving some support for the hypothesis. Finally, three studies examining 5-HT1A receptors
with [carbonyl-11C]WAY100635 (Rabiner et al. 2002 ;
Borg et al. 2003 ; Karlsson et al. 2009) and one examining
serotonin transporter 5-HTT with [11C]-3-amino-4-(2dimethylaminomethyl-phenylsulfanyl)-benzonitrile
([11C]DASB) (Reimold et al. 2008) in healthy subjects
found no correlation between serotonin function
and HA.
5-HTT is the main mechanism for terminating synaptic 5-HT transmission (Bengel et al. 1998). Studies on
5-HTT knock-out mice and rats (Wellman et al. 2007 ;
Kalueﬀ et al. 2010) show that a dysregulated serotonin
system plays a role in the modulation of both negative
emotionality and aggressive behaviour, i.e. the two
ends of the HA dimension. Except for the raphe nuclei,
5-HTT is located predominantly in axon terminals of
serotonergic neurons (Sur et al. 1996), making a 5-HTT
tracer an excellent tool to study serotonergic innervation.
The present study is designed to test an association
of HA and serotonin function in high- and low-HA
subjects speciﬁcally selected to be free of psychiatric
disorders in order to avoid possible state phenomena
associated, e.g. with aﬀective disorders (Reimold et al.
2008 ; Selvaraj et al. 2011). A validated tracer [11C]N,Ndimethyl-2-(2-amino-4-methylphenylthio)benzylamine
([11C]MADAM) and a three-dimensional PET technique were used to assess the 5-HTT density (binding
potential ; BPND) (Lundberg et al. 2005, 2006). To create
high- and low-HA subpopulations we used an ‘ oversampling ’ method in a large population cohort with
pre-existing Temperament and Character Inventory
(TCI) scores (Raitakari et al. 2008). The idea was to
enrich the diﬀerences between the groups and hence
increase the statistical power to detect any links between 5-HTT density and HA. We expected to detect
higher 5-HTT density in the high-HA group. We also
investigated the biology (5-HTT density) of character
dimensions as postulated by the model and also as
recent studies show that genetic factors play a greater
role in character development than originally suggested (see Cloninger, 2004).
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Method
This study is a part of a larger ‘ Neurobiology of
Personality ’ project at the University of Turku and
University of Helsinki, Finland. The current study
protocol was approved by the Joint Ethical Committee
(EC) of the University of Turku and the Turku
University Central Hospital. After having received all
the relevant information in written form from the
investigators, all study subjects gave EC-approved
written consents. This study followed the ethical
guidelines of the Declaration of Helsinki.

Subjects
The subjects were derived from a population-based,
prospective cohort study called The Cardiovascular
Risk in Young Finns Study (Akerblom et al. 1985). The
cohort originally consisted of 3596 randomly selected
healthy individuals from six age cohorts (3, 6, 9, 12, 15
and 18 years) at baseline in 1980. This cohort has now
been followed up for 29 years, and examined up to
eight times during this interval (Raitakari et al. 2008).
The loss-to-follow-up rate is low in the cohort ; at the
time of the subject selection (2001), still 68 % of the
original sample was participating.
Subjects belonging consistently to the highest or
lowest quartiles on HA in both follow-ups (in 1997 and
2001) and having complete TCI data available were
included (n=2075). For logistic reasons, only subjects
living in Turku or Helsinki area and from rural communities in their vicinity were included into this
selection. Background information gathered in the cohort study (Raitakari et al. 2008) was used to exclude
subjects with known chronic somatic diseases, psychiatric illnesses, excess alcohol consumption or body
mass index over 35 kg/m2 from the initial selection.
The subjects were then matched for age (six original
age cohorts were combined into three), gender and
education (low, intermediate, high). This resulted in a
group of 82 matched subjects from which recruiting
for this study was made.
From the group of 82 matched subjects, 12 were
unobtainable and 34 were excluded based on telephone interview (15 refused, 10 had somatic diseases,
seven were regular smokers and two were pregnant).
Of the 82 eligible subjects, ﬁve were not contacted at
all, because the matched groups they would have been
representing were already fulﬁlled by other subjects.
A total of 31 subjects were interviewed by a psychiatrist (P.L. or T.M.) using the Structured Clinical
Interview for DSM-IV and Hamilton Depression
Rating Scale. A total of nine subjects were excluded for
fulﬁlling Diagnostic and Statistical Manual of Mental
Disorders, Fourth Edition (DSM-IV) diagnostic criteria
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Table 1. Characteristics of high- and low-HA groups
High HA (n=10)
Gender, n
Male
Female
Mean age, years (S.D.)
Education, n
Low
Higha
Mean HA score (range)

Low HA (n=11)

p
0.835

5
5
37.6 (5.14)

6
5
38.1 (5.43)

0.837
0.528

5
5
3.3 (2.97–3.66)

4
7
2.0 (1.71–2.23)

<0.001

HA, Harm avoidance ; S.D., standard deviation.
a
High education refers to graduation from university.

for one or more psychiatric disorders : major depression (n=5), panic disorder (n=2), social phobia
(n=1) and alcohol abuse (n=1). All the subjects excluded on the basis of psychiatric diagnosis had high
HA scores. Somatic health was conﬁrmed prior to PET
study with blood and urine tests, electrocardiogram
and clinical examination.
The ﬁnal study group consisted of 22 subjects – 10
subjects in the high-HA group and 12 subjects in the
low-HA group. Characteristics of the high- and lowHA groups are presented in Table 1. One low- and one
high-HA subject used nicotine products whereas the
others did not. None of the volunteers was taking any
medications at the time of the study and one low-HA
subject was excluded from the ﬁnal analysis because
of considerable movement indicated by the external
motion detector during the PET scan resulting in a
low-HA group of 11 subjects. All subjects underwent
T1- and T2-weighted magnetic resonance (MR)
imaging at 1.5 T to rule out structural brain abnormalities and to obtain an anatomical reference for
quantiﬁcation of PET images (T1).
TCI
Temperament and character traits were self-rated by
the participants using the Finnish translation of the
ninth version of Cloninger’s Temperament and Character Inventory (Cloninger et al. 1993). The inventory
consists of four temperament scales (HA, ‘ novelty
seeking ’, ‘ reward dependence ’ and ‘ persistence ’) and
three character scales (‘ self-directedness ’, ‘ cooperativeness ’ and ‘ self-transcendence ’), which were assessed with 40, 35, 24, 8, 44, 42 and 33 items,
respectively ; 226 items in total. Instead of the original
dichotomous true/false format, the items were rated
on a ﬁve-point Likert scale ranging from totally disagree (1) to totally agree (5). We calculated a mean
score for every participant for each of the seven scales

by averaging each participant’s answers over all of the
items comprising one scale, thus resulting in an average score for each scale that ranged from 1 to 5.
The Cronbach a reliabilities for the scales in the total
Cardiovascular Risk in Young Finns Study sample
were : HA, a=0.92 ; ‘ novelty seeking ’, a=0.85 ;
‘ reward dependence ’, a=0.80 ; ‘ persistence ’, a=0.64 ;
‘ self-directedness ’, a=0.91 ; ‘ cooperativeness ’, a=
0.91 ; and ‘ self-transcendence ’, a=0.91. The content
and construct validity of the measure has been shown
to be high in previous studies with Finnish samples
(Keltikangas-Jarvinen et al. 1999).
Radiochemistry
N-desmethyl-MADAM and and MADAM were obtained from PharmaSynth AS (Estonia). High speciﬁc
radioactivity [11C]methyl iodide was prepared from
[11C]methane (Larsen et al. 1997 ; Någren et al. 2003).
Preparation of [11C]MADAM
The preparation of [11C]MADAM from [11C]methyl
triﬂate was performed according to a published procedure (Halldin et al. 2005) with minor modiﬁcations.
[11C]methyl triﬂate, prepared on-line from [11C]methyl
iodide, was reacted with 0.4–0.6 mg of N-desmethylMADAM in 200 ml acetone. The crude product was
puriﬁed using high-performance liquid chromatography (HPLC) on a mBondapak1 column (Waters,
USA) using 40 % acetonitrile in 0.1 M-ammonium formiate. After the addition of 0.3 ml of sterile propylene
glycol–ethanol (7 : 3, v/v) the fraction containing the
product was evaporated and re-dissolved in 8 ml
physiological phosphate buﬀer (0.1 M, pH 7.4) and ﬁltered through a 0.2 mm Gelman Acrodisc1 4192 sterile
ﬁlter. The radiochemical purity and the speciﬁc
radioactivity of the product were determined using
HPLC and ultra-violet detection at 242 nm. The volume of the ﬁnal product solution was calculated by
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(a)
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(c)

Fig. 1. Uptake of [11C]N,N-dimethyl-2-(2-amino-4-methylphenylthio)bene ([11C]MADAM) in the human brain showing
(a) coronal, (b) sagittal and (c) axial slices (integrated images from 0–75 min). The highest uptake is observed in the midbrain
and the lowest in the cerebellum.

weighing the sterile product vessel before and after
sterile ﬁltration and division with the density of the
sterile solvent.

low-HA group. There were no statistically signiﬁcant
diﬀerences in injected mass or dose. Emission data
was collected in list mode for 75 min as 17 frames of
increasing length (3r1 min, 4r3 min and 10r6 min).

PET procedures
PET imaging was carried out using a brain-dedicated
high-resolution PET scanner (ECAT HRRT ; Siemens
Medical Solutions, USA) (Rahmim et al. 2005).
Methods used for attenuation correction, acquiring
emission data and reconstruction are described in an
earlier report by our group (Hirvonen et al. 2008).
Head ﬁxation was achieved by using an individually
moulded thermoplastic mask. External motion data
was acquired using the Polaris Vicra showing movements within the spatial resolution (FWHM) of the
scanner.
Serotonin transporter (5-HTT) density was
measured using the highly speciﬁc [11C]MADAM
tracer (Lundberg et al. 2005) (see Fig. 1). An intravenous bolus of [11C]MADAM was injected and
ﬂushed with saline. The injected dose and mass of
[11C]MADAM were 475 (S.D.=70.6) MBq and 0.42
(S.D.=0.19) mg for the high-HA group and 484
(S.D.=33.6) MBq and 0.73 (S.D.=0.50) mg for the

Image analysis
To correct for head motion during the scan a frame-toframe correction was done using external motion data
to assess the frames of least motion. These frames were
then summed and used as a reference for realignment.
The MR images were co-registered to PET images. All
realignment and co-registration procedures were performed using Statistical Parametric Mapping software
version 2 (SPM2 ; Friston et al. 1995).
Quantiﬁcation of tracer binding
The a priori regions of interest (ROIs) were manually
delineated on T1-weighted transaxial MR images
that had been co-registered to PET images into 22
diﬀerent regions using Imadeus software (version 1.4 ;
Forima Inc., Finland). ROIs were drawn onto the
dorsal, pregenual and subgenual anterior cingulate
cortex, which was deﬁned as suggested by
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Drevets et al. (2002). In the prefrontal cortex, dorsolateral and ventrolateral prefrontal cortex, medial
frontal cortex, lateral and medial orbital frontal cortex
were delineated. ROIs on the dorsal caudate, dorsal
putamen and ventral striatum were deﬁned as described (Hirvonen et al. 2008). The insular cortex
was separated into two parts, anterior and posterior
(Cannon et al. 2007). ROIs were also drawn onto the
thalamus, amygdala, hippocampus, inferior, medial
and superior temporal gyrus, supramarginal gyrus,
angular gyrus and posterior cingulate cortex and cerebellum. Because speciﬁc serotonin-rich areas/nuclei
in the midbrain, pons and medulla cannot be diﬀerentiated in MR images, the analysis of this region
was conducted solely with a voxel-based approach.
The term ‘ midbrain ’ in this paper refers to a search
area including the midbrain, pons and upper medulla
unless otherwise indicated.
ROIs were used to calculate regional time–
radioactivity curves (TACs) from dynamic PET
images. The simpliﬁed reference tissue model
(Lammertsma & Hume, 1996) was applied to TACs to
derive 5-HTT BPND (Innis et al. 2007), which represents
the ratio at equilibrium of speciﬁc to non-displaceable
ligand binding in brain tissue and is linearly related
to receptor density. The cerebellum was used as a
reference region.
Statistical analysis of ROI-based data
To examine the group diﬀerence in [11C]MADAM
BPND we used repeated-measures analysis of variance
(ANOVA) with region as a within subject factor and
group as a between-subjects factor. Because HA correlated with ‘ novelty seeking ’, ‘ self-directedness ’ and
‘ cooperativeness ’, we also performed an exploratory
analysis of covariance to examine whether a group
diﬀerence could be detected when ‘ self-directedness ’,
‘ cooperativeness ’ and ‘ novelty seeking ’ were controlled for.
To explore the associations of other temperament
and character traits with [11C]MADAM BPND, we
combined the two groups into one and in ROI-based
data the associations were tested using partial correlation coeﬃcient while controlling for age and gender.
Age was selected because of its demonstrated eﬀect on
5-HTT density (Van Dyck et al. 2000) and eﬀects on
character scores (Cloninger et al. 1993). Gender was
chosen because it had an eﬀect on 5-HTT binding in
our sample as well as in earlier studies (Jovanovic et al.
2008).
In this study, a p value below 0.05 was considered
statistically signiﬁcant and normality of distribution
was conﬁrmed using the Shapiro–Wilk test. All
ROI-based statistical analyses were carried out with

version 17 of SPSS statistical software for Windows
(release 17.0.0 ; SPPS Inc., USA).
Voxel-based analysis
Because of the complex anatomy of serotonergic
nuclei in the midbrain, this region was analysed separately from the rest of the brain. Thus two voxel-wise
analyses were conducted using SPM5 (Wellcome
Department of Cognitive Neurology, London, UK)
running on Matlab for Windows (version 7.4.0.287 ;
MathWorks, USA). First, a ROI containing the midbrain, pons and medulla [deﬁned with Wake
Forest University (WFU) PickAtlas software ; http://
www.nitrc.org/projects/wfu_pickatlas/] was analysed and then another, conﬁrmatory voxel-wise
analysis was carried out on the whole brain excluding
the midbrain ROI.
The conﬁrmatory analysis was carried out as
previously described (Hirvonen et al. 2005). Preprocessing of parametric images and statistical analyses were performed using SPM5. Parametric images
were calculated with a simpliﬁed reference tissue
model applied to all voxels with the cerebellum as a
reference region. Images were spatially normalized to
Montreal Neurological Institute (MNI) space using
summed PET images and a ligand-speciﬁc template
for [11C]MADAM. Spatially normalized parametric
images were smoothed using an 8-mm Gaussian
kernel.
Diﬀerences between high-HA and low-HA groups
were analysed using an independent two-sample
t test. To test the association of other TCI traits and
[11C]MADAM BPND in the combined group, a multiple
regression analysis was performed with age and gender as nuisance variables. In the midbrain ROI analysis false discovery rate (0.05) was used to correct for
multiple comparisons. Cluster-level-corrected p values
<0.05 were considered statistically signiﬁcant.

Results
[11C]MADAM BPND in high- and low-HA groups
A ROI-based repeated-measures ANOVA indicated
that [11C]MADAM BPND did not diﬀer in any brain
region between the high- and low-HA groups
(F=0.961, p=0.408) (Fig. 2). In addition, there was no
signiﬁcant regionrgroup interaction in this analysis.
A voxel-based analysis conﬁrmed the negative result.
Finally, a separate analysis on the midbrain indicated
no diﬀerences between the high- and low-HA groups.
Because of the known intercorrelations between
HA and ‘ novelty seeking ’, ‘ cooperativeness ’ and
‘ self-directedness ’, we included also these TCI
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Fig. 2. Examples of [11C]N,N-dimethyl-2-(2-amino-4-methylphenylthio)benzylamine ([11C]MADAM) binding potential (BPND)
in three diﬀerent brain regions : (a) subgenual anterior cingulate cortex ; (b) dorsolateral prefrontal cortex ; (c) amygdala.
Statistically signiﬁcant diﬀerences were not found in any region (p>0.05).

(a)

(b)

Mean cluster values of dorsal raphe nucleus

[11C]MADAM BPND
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1.0
0.8
0.6
2.0

2.5

3.0

3.5

4.0

4.5

5.0

Self-directedness
Fig. 3. ‘ Self-directedness ’ correlates with serotonin transporter (5-HTT) binding potential in the dorsal raphe nucleus (n=21).
(a) The results are visualized on an anatomically standardized T1-weighted magnetic resonance image. Cluster-level p=0.004
(corrected for multiple comparisons). Cluster size=199 voxels. Montreal Neurological Institute (MNI) x, y, z coordinates in
millimetres of peak voxel x4, x26, x4. (b) Individual mean binding potential (BPND) values extracted from the cluster using the

dimensions in the statistical model but the results did
not change.

comparisons. ‘ Self-transcendence ’ did not correlate
with [11C]MADAM BPND in any region. A voxel-based
analysis was in line with the ROI-based ﬁndings.

Correlations between TCI character dimensions
and [11C]MADAM BPND

TCI scores

Voxel-based analysis restricted to the midbrain revealed a signiﬁcant positive correlation between ‘ selfdirectedness ’ and [11C]MADAM BPND in a cluster of
voxels localized in the dorsal raphe nucleus (r=0.555,
p=0.004 after correction for multiple comparisons)
(Fig. 3). In contrast, partial correlation analysis of ROIbased data revealed negative correlations between
[11C]MADAM BPND and ‘ self-directedness ’ as well as
between [11C]MADAM BPND and ‘ cooperativeness ’ in
several brain regions such as the anterior insula and
posterior cingulate cortex (Table 2). Nevertheless, these
correlations did not survive correction for multiple

The mean HA scores were 3.32 (range 2.97–3.66) in the
high-HA group and 2.00 (range 1.71–2.23) in the lowHA group (p<0.001). All correlations between TCI
dimensions in the current subsample and in the whole
cohort are shown in Supplementary Tables S1a and
S1b. HA scores showed excellent stability over time,
demonstrated by a Pearson correlation of 0.852 between HA scores obtained on the PET study day and
those obtained in the year 2001. Age or gender did not
aﬀect TCI scores in our sample.
TCI mean character scores in our subsample were
as follows : ‘ self-directedness ’, 3.65 (range 2.60–4.58) ;
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Table 2. ‘ Self-directedness ’ and ‘ cooperativeness ’ partial correlations with regional [11C]MADAM BPND (n=21)a
‘ Self-directedness ’
Brain regions

rb

‘ Cooperativeness ’
pc

rb

pc

Cingulate cortex
Subgenual
Pregenual
Anterior dorsal
Posterior

x0.203
x0.339
x0.362
x0.658

0.403
0.156
0.127
0.002**

x0.224
x0.424
x0.271
x0.444

0.357
0.07
0.262
0.057

Basal ganglia
Caudate nucleus
Putamen
Ventral striatum
Thalamus

x0.177
x0.394
x0.241
0.025

0.468
0.095
0.32
0.919

x0.327
x0.586
x0.252
x0.007

0.172
0.008**
0.298
0.976

Temporal lobe
Superior temporal gyrus
Medial temporal gyrus
Inferior temporal gyrus
Anterior insular cortex
Posterior insular cortex
Hippocampus
Amygdala

x0.196
x0.237
x0.242
x0.614
x0.369
0.423
x0.208

0.421
0.328
0.318
0.005**
0.12
0.071
0.380

x0.358
0.466
x0.233
x0.547
x0.387
0.472
x0.115

0.133
0.044*
0.338
0.015*
0.102
0.041*
0.631

Frontal lobe
Medial prefrontal cortex
Medial orbital frontal cortex
Lateral orbital frontal cortex
Dorsolateral prefrontal cortex
Ventrolateral prefrontal cortex

x0.508
x0.451
x0.205
x0.425
x0.002

0.026*
0.052
0.386
0.069
0.994

x0.52
x0.42
x0.22
x0.41
x0.093

0.023*
0.074
0.352
0.082
0.706

[11C]MADAM, [11C]N,N-dimethyl-2-(2-amino-4-methylphenylthio)benzylamine ; BPND, binding potential.
Relevant midbrain results are shown in Fig. 3.
b
Partial correlation coeﬃcient (partial correlation analysis corrected for age and gender).
c
Signiﬁcance values were not corrected for multiple comparisons.
* p<0.05, ** p<0.01.
a

‘ cooperativeness ’, 3.76 (range 3.15–4.31) ; ‘ selftranscendence ’, 2.37 (range 1.35–3.42). These scores
were not statistically diﬀerent from those observed
in the whole cohort (n=2075 in the year 2001),
which were as follows : ‘ self-directedness ’, 3.70 (range
1.94–4.88) ; ‘ cooperativeness ’, 3.74 (range 1.50–4.84) ;
‘ self-transcendence ’, 2.49 (range 1.18–4.38) and the
scores in the subsample were normally distributed.
‘ Self-directedness ’, ‘ cooperativeness ’ and ‘ selftranscendence ’ also showed stability over the two
measurement points (1997 and 2001), with Pearson
correlation coeﬃcients of 0.926, 0.875 and 0.787,
respectively.

pattern was seen in several other brain regions but
these diﬀerences were not statistically signiﬁcant after
correction for multiple comparisons.
We observed a trend towards negative correlations
with age and [11C]MADAM BPND, e.g. in the angular
gyrus (r=x0.471, p=0.031) and in the posterior insula
(r=x0.433, p=0.05), but these correlations did not
survive correction for multiple comparisons. The failure to detect an age-related decline in [11C]MADAM
BPND is probably due to the small age range
(15.8 years) in the subsample.

Discussion
[11C]MADAM BPND in the brain – eﬀect of gender
and age

Serotonin transporter and HA in screened healthy
subjects

Voxel-based analysis in the midbrain indicated that
females had signiﬁcantly higher [11C]MADAM BPND
in the midbrain (p<0.001, corrected). This same

Serotonin is a predominantly inhibitory neurotransmitter in the adult human brain. Outside the
raphe nucleus 5-HTTs are located presynaptically in

Temperament, character and serotonin activity in the brain
the serotonergic axon terminals where they critically
regulate the amount of serotonin in the synaptic cleft
by reuptake. In this study our hypothesis was not
supported, i.e. the temperament dimension HA was
not associated with 5-HTT density (BPND) in healthy
volunteers. This was the case despite the speciﬁc study
design to detect diﬀerences in the age- and gendermatched high- and low-HA groups. Results did not
change after including other modifying TCI personality traits in the model (‘ novelty seeking ’, ‘ selfdirecetedness ’, ‘ cooperativeness ’). Our result is in line
with the study by Reimold et al. (2008), which did not
detect an association between HA and [11C]DASB
BPND in 19 healthy volunteers. We intentionally excluded subjects with past or current DSM-IV-deﬁned
psychiatric disorders in order to avoid eﬀects of, for
example, aﬀective disorder diagnosis or its treatment
on our results. Excluding subjects with mental disorders from this study limits the generalizability of the
results to the healthy population. Exclusion of subjects
with mental disorders is a valid approach, as some
reports suggest decreased in vivo 5-HTT binding in
major depression although this remains controversial
with possible state-dependent phenomena involved
(Bhagwagar et al. 2007 ; Cannon et al. 2007 ; Meyer,
2007 ; Reimold et al. 2008 ; Selvaraj et al. 2011). It is
known that high HA predisposes to psychiatric disorders, especially in the mood and anxiety spectrum
(see Miettunen & Raevuori, 2012). Our results are
useful in the interpretation of serotonin imaging
studies in patients with aﬀective disorders and the
related state–trait discussion. Future serotonin
imaging studies should examine high- and low-HA
subjects with and without psychiatric disorders in order to explore the interaction between temperament
and, for example, mood and anxiety spectrum
diagnosis. Clearly, such a study would also be of high
relevance for further testing of Cloninger’s psychobiological model of personality and the original
hypothesis on the link between serotonin and HA in
the general population.
Neither ROI-based data nor voxel-based analysis of
parametric BPND images showed diﬀerence between
high- and low-HA groups in [11C]MADAM BPND
in any brain region. Power analysis of ROI-based data
(at a=0.05, b=0.20) indicated that we can exclude
17 % diﬀerence in striatum and 16 % diﬀerence in anterior cingulate cortex in [11C]MADAM BPND between
the groups.
BPND is a composite measure of aﬃnity and density
(Innis et al. 2007), which are not separable from the
PET procedure used here. Our interpretation of the
ﬁnding is that HA does not aﬀect 5-HTT density. An
acute change in serotonin levels does not aﬀect 5-HTT
binding in vivo in humans (Praschak-Rieder et al. 2005 ;
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Talbot et al. 2005). Unchanged 5-HTT level, albeit a key
regulator of serotonin drive, does not exclude a
change in endogenous 5-HT levels between the two
HA groups. Unfortunately, there are currently no established methods of measuring 5-HT levels directly
or indirectly in man despite promising new results
with a 5-HT1B receptor tracer (Finnema et al. 2010).
Moreover, our result does not exclude the possibility
that HA is linked to the density or function of 5-HT
receptors. To our knowledge there are four earlier
imaging studies on HA and serotonin receptor density
in healthy volunteers (Moresco et al. 2002 ; Rabiner
et al. 2002 ; Borg et al. 2003 ; Karlsson et al. 2009). Of
these studies, three used a 5-HT1A receptor tracer
[carbonyl-11C]WAY-100635 (Rabiner et al. 2002 ; Borg
et al. 2003 ; Karlsson et al. 2009) and none of them
found an association between receptor density and
HA. Considering that the combined number of
healthy subjects in these studies is 96, we think that it is
unlikely that HA is related to 5-HT1A receptor density
in the healthy population. The fourth study (Moresco
et al. 2002) using [18F]FESP found a negative correlation
between [18F]FESP binding and HA bilaterally in the
frontal cortex and in the left parietal cortex. [18F]FESP is
a ligand that binds to both 5-HT2A and dopamine D2
receptors, and is thus not an ideal tracer for imaging
the serotonin 5-HT2A receptors.
Interestingly, in an [18F]altanserin PET study
on NEO Personality Inventory (NEO-PI) – Revised
‘ neuroticism ’, Frokjaer et al. (2008) found a positive
correlation between ‘ neuroticism ’ and 5-HT2A receptor binding in frontolimbic regions. Although HA and
‘ neuroticism ’ are not directly comparable, they are
highly intercorrelated (De Fruyt et al. 2000 ; Jokela &
Keltikangas-Järvinen, 2011) and may both be seen
as vulnerability markers for aﬀective disorders. One
might thus expect somewhat related biology, not the
opposite as seen in the studies by Moresco et al. (2002)
and Frokjaer et al. (2008). It is possible that this
controversy simply demonstrates the possible pitfalls
of association studies where some neurobiological
marker is correlated with numerous psychological
traits in a relatively small study sample. ‘ Neuroticism ’
is also strongly correlated with ‘ self-directedness ’
(De Fruyt et al. 2000). Hence the ﬁndings by Frokjaer
et al. (2008) may be in agreement with our results
on ‘ self-directedness ’. Overall, our results and the
current literature do not support the hypothesized
association between HA and 5-HTT or receptor binding in subjects selected for an absence of psychiatric
disorders.
As the serotonergic system is intertwined with
several other neurotransmitters such as dopamine
and c-amino butyric acid (GABA), the HA trait
may be correlated with the balance of a complex
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neurotransmitter network instead of just serotonin.
There is one study that associates HA with dopamine
D2/D3 receptor availability in the associative and
sensorimotor striatum (Kim et al. 2011). In future,
neurobiological correlates of human personality
should be studied with a multiple neurotransmitter
approach as postulated earlier by Cloninger (1986).
Such diﬀerences in neurotransmitter balances are now
widely being searched (Nakamura et al. 2010).
Serotonin transporter and character in screened
healthy subjects
Our secondary analyses indicated that ‘ selfdirectedness ’ correlates positively with [11C]MADAM
BPND in the raphe nucleus. Negative correlations
between 5-HTT BPND values and ‘ self-directedness ’
as well as ‘ cooperativeness ’ were seen in multiple
brain areas, but these correlations did not survive a
conservative correction for multiple comparisons.
‘ Self-directedness ’ is related to self-concepts and
deﬁned as the extent to which a person identiﬁes
himself as an autonomous individual (Cloninger et al.
1993) and as the ability to adapt behaviour according
to chosen goals and values. The heritability of ‘ selfdirectedness ’ is high and in several studies it may be
even higher than that for the four temperament traits
(Comings et al. 2000 ; Ando et al. 2002, 2004 ; Gillespie
et al. 2003 ; Isen et al. 2009). However, little is known
about the biology of character dimensions. There is
some evidence for a link between serotonin systems
and character dimensions. Borg et al. (2003) found an
association between ‘ self-transcendence ’ and 5-HT1A
binding, but this has not been conﬁrmed by other
studies (Rabiner et al. 2002 ; Karlsson et al. 2009). None
of the 5-HT1A PET imaging studies found correlations
between 5-HT1A and ‘ self-directedness ’ or ‘ cooperativeness ’. As far as we know, this is the ﬁrst in vivo
imaging study that demonstrates the role of serotonin
in ‘ self-directedness ’. We found no statistically signiﬁcant correlations between [11C]MADAM BPND and
other character dimensions.
Higher ‘ self-directedness ’ was robustly associated
with higher 5-HTT binding in the dorsal raphe nucleus. Even if the result must be regarded as preliminary, the correlation was found in a relevant brain
region, survived correction for multiple comparisons
and was found in small volume-corrected and even in
a whole-brain SPM analysis. In addition, the distribution of ‘ self-directedness ’ scores in the current
sample was comparable with that in the larger population sample. Serotonergic neurons projecting to
other areas of the brain originate mainly from this
region (Hornung, 2003). The ﬁring rate of the
serotonergic neurons in the dorsal raphe nucleus is

controlled by autoregulatory 5-HT1A receptors by
negative feedback. 5-HTT in the raphe nucleus is
located in the somatodendritic part of the neuron in
contrast to other brain areas where 5-HTT is found on
the presynaptic axon terminals. High levels of 5-HTT
in the dorsal raphe nucleus is likely to cause less
negative autoregulation via the 5-HT1A receptor and a
higher serotonin drive in the terminal areas, e.g. in the
orbitofrontal or cingulate cortices. Our interpretation
of the ﬁnding is that higher ‘ self-directedness ’ is related to less negative feedback in the dorsal raphe
nucleus and thus with higher serotonergic drive in
terminal areas, e.g. in the orbitofrontal and cingulate
cortices.
Low levels of serotonin are thought to be essential
in the pathophysiology of aﬀective disorders. As noted
in the introduction, a low ‘ self-directedness ’ score
may also predispose to these disorders. Although the
results from imaging studies on serotonin and depression are still somewhat inconsistent (for a review,
see Meyer, 2007), the latest reports using [11C]DASB
report lower 5-HTT binding in the midbrain and
higher 5-HTT binding in cortical areas in depressed
patients compared with healthy controls (Parsey et al.
2006 ; Cannon et al. 2006, 2007 ; Reimold et al. 2008 ;
Selvaraj et al. 2011). Our results are consistent with
these ﬁndings. In fact, in future imaging studies on
mood and anxiety disorders, it would be useful to
consider the personality traits in the design and
analysis in order diﬀerentiate between predisposing
factors and factors related to the active disease process
itself.
Character scales were ﬁrst designed as targets
of psychotherapeutic interventions (Cloninger et al.
1994). However, some evidence indicates that treatment of aﬀective disorders with tricyclic antidepressants and selective serotonin reuptake
inhibitors, drugs that increase the levels of synaptic
serotonin, also increases ‘ self-directedness ’ (Black &
Sheline, 1997 ; Allgulander et al. 1998 ; Agosti &
McGrath, 2002 ; Hirano et al. 2002 ; Joyce et al. 2003 ;
Boz et al. 2007). One study has even indicated that this
increase in ‘ self-directedness ’ has also predictive
value for changes in depressive symptoms as
measured with BDI (Mazza et al. 2009). Therefore,
character dimensions may modulate the expression
of mood states (Farmer et al. 2003 ; Cloninger, 2004 ;
Cloninger et al. 2010) and our results may shed
light on why both depressive symptoms and ‘ selfdirectedness ’ improve during serotonin-altering psychopharmacological treatment.
Finally, it should be noted that the validity of the
distinction between temperament and character traits
has been questioned, as factor analyses show a high
degree of cross-loading between the traits (Ball et al.
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1999 ; Herbst et al. 2000 ; Gana & Trouillet, 2003). In line
with these factor analyses, the Pearson correlation coeﬃcient between HA and ‘ self-directedness ’ in the
whole Young Finns Study cohort was high (r=x0.63,
see Supplementary Table S1a). De Fruyt et al. (2000)
reported an equally high Pearson correlation coefﬁcient (r=x0.63) between NEO-PI ‘ neuroticism ’ and
TCI ‘ self-directedness ’. However, even if two traits do
correlate and load on the same factor, they may still
represent psychologically distinct constructs (Block,
1995). Future studies investigating the role of the
serotonin system in human personality should take
these limitations in the TCI model into consideration,
but also appreciate that the NEO-PI and TCI have high
intercorrelations.

Conclusions
We found no support for an association of HA and
serotonin transporter density in subjects free of psychiatric disorders as measured with [11C]MADAM and
PET. The result has implications in the research for
biological factors in aﬀective disorders. Higher serotonin transporter density in the dorsal raphe nucleus
predicted higher ‘ self-directedness ’ scores. This relationship was robust and warrants further studies of
serotonin function, diﬀerential aspects of character
development and psychopathology.

Supplementary material
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